Raloxifene (30mg x50) – Selective Estrogen Receptor Modulator (SERM)

Raloxifene, available in 30mg tablets, belongs to the class of medications known as selective estrogen receptor modulators (SERMs). It is primarily prescribed to prevent and treat osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of breast cancer. Raloxifene works by mimicking the effects of estrogen in some parts of the body while blocking estrogen’s effects in other areas.

Key Benefits:

• Osteoporosis Prevention and Treatment: Raloxifene helps increase bone mineral density and reduce the risk of fractures in postmenopausal women with osteoporosis.
• Breast Cancer Risk Reduction: Raloxifene has been shown to reduce the risk of invasive breast cancer in postmenopausal women at high risk of developing the disease.
• Cardiovascular Protection: Some studies suggest that Raloxifene may have beneficial effects on cardiovascular health, including reducing the risk of heart attack and stroke.

Half-life:

• Approximately 1.4 days

Possible Dosage & Cycle Length:

• Men can consider a daily dosage of 30 mg during the cycle, adjusting as necessary to manage side effects.
• Use by women outside of clinical settings is not advised.

Safety Considerations:

• Raloxifene may increase the risk of blood clots, stroke, and other serious side effects. It is essential to discuss the potential risks and benefits of treatment with a healthcare provider before starting Raloxifene.
• Common side effects of Raloxifene may include hot flashes, leg cramps, and flu-like symptoms.